PolyPeptide Group AG
SIX:PPGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sunedison Infrastructure Ltd
BSE:531260
|
IN |
|
New Jersey Resources Corp
NYSE:NJR
|
US |
|
Grand Field Group Holdings Ltd
HKEX:115
|
HK |
PolyPeptide Group AG
Other Equity
PolyPeptide Group AG
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Other Equity
€21m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Other Equity
-CHf61.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Other Equity
-CHf292.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Other Equity
-CHf1.7B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
|
Tecan Group AG
SIX:TECN
|
Other Equity
-CHf174.7m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
See Also
What is PolyPeptide Group AG's Other Equity?
Other Equity
21m
EUR
Based on the financial report for Dec 31, 2025, PolyPeptide Group AG's Other Equity amounts to 21m EUR.
What is PolyPeptide Group AG's Other Equity growth rate?
Other Equity CAGR 3Y
14%
Over the last year, the Other Equity growth was -2%. The average annual Other Equity growth rates for PolyPeptide Group AG have been 14% over the past three years .
